Dr. Maciej Mrugala, MD

Claim this profile

Mayo Clinic

Studies Brain Tumor
Studies Glioblastoma
4 reported clinical trials
8 drugs studied

Area of expertise

1Brain Tumor
Maciej Mrugala, MD has run 3 trials for Brain Tumor. Some of their research focus areas include:
H3 K27M positive
2Glioblastoma
Maciej Mrugala, MD has run 2 trials for Glioblastoma. Some of their research focus areas include:
MET positive
MET negative

Affiliated Hospitals

Image of trial facility.
Mayo Clinic
Image of trial facility.
Mayo Clinic Arizona

Clinical Trials Maciej Mrugala, MD is currently running

Image of trial facility.

ONC201

for Brain Tumor

This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with ONC201 following frontline radiotherapy will extend overall survival and progression-free survival in this population. Eligible participants will have histologically diagnosed H3 K27M-mutant diffuse glioma and have completed standard frontline radiotherapy.
Recruiting1 award Phase 3

More about Maciej Mrugala, MD

Clinical Trial Related8 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Maciej Mrugala, MD has experience with
  • Berubicin
  • Lomustine
  • Gliadel Wafer
  • ONC201
  • Retifanlimab
  • Bevacizumab
Breakdown of trials Maciej Mrugala, MD has run
Brain Tumor
Glioblastoma
Mesial Temporal Sclerosis

Other Doctors you might be interested in

Aminah Jatoi, M.D.Mayo Clinic in Rochester
Jeremy Thaden, MDMayo Clinic
sikander ailawdhi, mdMayo Clinic

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maciej Mrugala, MD specialize in?
Maciej Mrugala, MD focuses on Brain Tumor and Glioblastoma. In particular, much of their work with Brain Tumor has involved H3 K27M positive patients, or patients who are undergoing treatment.
Is Maciej Mrugala, MD currently recruiting for clinical trials?
Yes, Maciej Mrugala, MD is currently recruiting for 1 clinical trial in Phoenix Arizona. If you're interested in participating, you should apply.
Are there any treatments that Maciej Mrugala, MD has studied deeply?
Yes, Maciej Mrugala, MD has studied treatments such as Berubicin, Lomustine, Gliadel Wafer.
What is the best way to schedule an appointment with Maciej Mrugala, MD?
Apply for one of the trials that Maciej Mrugala, MD is conducting.
What is the office address of Maciej Mrugala, MD?
The office of Maciej Mrugala, MD is located at: Mayo Clinic, Phoenix, Arizona 85054 United States. This is the address for their practice at the Mayo Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top